Statistics

Total Visits

Views
Biomarkers for predicting taxane efficacy in ER+/HER2-breast cancer patients: From in-vitro chemosensitivity screening to clinical validation in the GEICAM/ 9906 trial49

Select a period of time:

Number of views in the range

Views
Biomarkers for predicting taxane efficacy in ER+/HER2-breast cancer patients: From in-vitro chemosensitivity screening to clinical validation in the GEICAM/ 9906 trial36

Views

Views
February 20250
March 202515
April 20252
May 20250
June 20254
July 202515
August 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
Brazil9
United States8
United Kingdom2
Spain1
Ireland1
 

Top cities views

Views
Belo Horizonte1
Brasília1
Caruaru1
Council Bluffs1
Dublin1
Duns1
Indianapolis1
Kansas City1
North Shields1
Phoenix1